Inovio Pharmaceuticals Inc vs Lowe`s Companies Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $76.09M), while Lowe`s Companies Inc trades at $220.63 (market cap $122.73B). The key difference: Lowe`s Companies Inc is far larger — about 1613× Inovio Pharmaceuticals Inc's market cap, and Lowe`s Companies Inc pays a 2.28% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | LOW | |
|---|---|---|
Market Cap | $76.09M | $122.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $287.39 |
52-Week Low | $0.66 | $201.92 |
Enterprise Value | $47.10M | $164.48B |
Dividend Yield | — | 2.28% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →